Title:
E1906 A Phase II Randomized Trial of Carboplatin and Topotecan; Flavopiridol, Mitoxantrone and Cytosine Arabinoside; and Sirolimus, Mitoxantrone, Etoposide and Cytosine Arabinoside for the Treatment of Adults with Primary Refractory or Initial Relapse of Acute Myelogenous Leukemia (AML)
Protocol Number:
E1906
Phase:
Phase II
Physician:
Keith Pratz
Purpose:
This is a randomized 3 Arm study of high dose chemotherapy which requires hospitalization for several weeks with close daily monitoring.
Eligibility:
Treatment:
Population:
Adult
Last Update
05/24/2013 04:02 AM
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts